Literature DB >> 24413013

Assessment of the presence and quality of osteoporosis prevention education among at-risk internal medicine patients.

Jennifer A Shulha1, Cortney B Sviggum2, John G O'Meara1, Melody L Berg3.   

Abstract

OBJECTIVE: Appropriate calcium and vitamin D intake for the prevention of osteoporosis represents an important component of osteoporosis prevention education (OPE). We sought to assess the presence and quality of OPE among osteoporotic and at-risk inpatients.
DESIGN: Prospective chart review plus cross-sectional interview.
SETTING: One academic tertiary referral medical center in Rochester, Minnesota. PARTICIPANTS: Adults admitted to an inpatient medicine service who were determined to be at risk for osteoporosis based on an investigator-developed screening tool or previously diagnosed with osteoporosis. Four hundred sixtyfour patients were screened, 192 patients were approached for participation, and 150 patients consented to be interviewed for the study. MAIN OUTCOME MEASURES: Source of OPE, rates of appropriate calcium intake and supplementation.
RESULTS: OPE from a health care provider was reported by 31.3% of patients, with only one patient reporting education from a pharmacist. Self OPE and no OPE were received by 29.3% and 39.3% of patients, respectively. Appropriate overall calcium intake was found in 30.7% of patients, and only 21.3% of patients were taking an appropriate calcium salt.
CONCLUSION: Patients with osteoporosis and risk factors for osteoporosis lack adequate education from health care providers regarding appropriate intake of dietary and supplemental calcium and vitamin D. A particular deficit was noted in pharmacist-provided education. Specific education targeting elemental calcium amounts, salt selection, and vitamin D intake should be provided to increase the presence of appropriate overall calcium consumption.

Entities:  

Keywords:  Calcium carbonate; Calcium citrate; DXA = Dual-energy x-ray absorptiometry; Dietary supplements; NOF = National Osteoporosis Foundation; OPE = Osteoporosis prevention education; Osteoporosis

Mesh:

Substances:

Year:  2014        PMID: 24413013      PMCID: PMC4254788          DOI: 10.4140/TCP.n.2014.39

Source DB:  PubMed          Journal:  Consult Pharm        ISSN: 0888-5109


  11 in total

Review 1.  Clinical inertia.

Authors:  L S Phillips; W T Branch; C B Cook; J P Doyle; I M El-Kebbi; D L Gallina; C D Miller; D C Ziemer; C S Barnes
Journal:  Ann Intern Med       Date:  2001-11-06       Impact factor: 25.391

2.  Managing osteoporosis in postmenopausal women.

Authors:  Sheryl F Vondracek
Journal:  Am J Health Syst Pharm       Date:  2010-04       Impact factor: 2.637

3.  Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial.

Authors:  Mary Beth O'Connell; Denyse M Madden; Anne M Murray; Robert P Heaney; Lawrence J Kerzner
Journal:  Am J Med       Date:  2005-07       Impact factor: 4.965

4.  Long-term proton pump inhibitor therapy and risk of hip fracture.

Authors:  Yu-Xiao Yang; James D Lewis; Solomon Epstein; David C Metz
Journal:  JAMA       Date:  2006-12-27       Impact factor: 56.272

Review 5.  Hypochlorhydric stomach: a risk condition for calcium malabsorption and osteoporosis?

Authors:  Pentti Sipponen; Matti Härkönen
Journal:  Scand J Gastroenterol       Date:  2010       Impact factor: 2.423

Review 6.  Screening for osteoporosis in the adult U.S. population: ACPM position statement on preventive practice.

Authors:  Lionel S Lim; Laura J Hoeksema; Kevin Sherin
Journal:  Am J Prev Med       Date:  2009-04       Impact factor: 5.043

7.  Calcium absorption and achlorhydria.

Authors:  R R Recker
Journal:  N Engl J Med       Date:  1985-07-11       Impact factor: 91.245

8.  Evaluation of compliance with osteoporosis treatment guidelines after initiation of a pharmacist-run osteoporosis service at a family medicine clinic.

Authors:  Larissa N Hall; Sarah P Shrader; Kelly R Ragucci
Journal:  Ann Pharmacother       Date:  2009-10-13       Impact factor: 3.154

9.  Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society.

Authors: 
Journal:  Menopause       Date:  2010 Jan-Feb       Impact factor: 2.953

10.  Compliance with osteoporosis treatment guidelines in postmenopausal women.

Authors:  Cary R Mountjoy; Sarah P Shrader; Kelly R Ragucci
Journal:  Ann Pharmacother       Date:  2009-02-05       Impact factor: 3.154

View more
  1 in total

1.  The Effectiveness of Osteoporosis Screening and Treatment in the Midwest.

Authors:  Dharmik Patel; John R Worley; David A Volgas; Brett D Crist
Journal:  Geriatr Orthop Surg Rehabil       Date:  2018-03-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.